BM8 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Biomarin Pharmaceutical Inc

Watchlist Manager

Watchlist

Price: 47.92 EUR -0.79%

Market Cap: €9.1B

B	Biomarin Pharmaceutical Inc F:BM8	US
	Capitaland Investment Ltd F:5NU	SG
I	Intesa Sanpaolo SpA DUS:IES	IT
	XSpray Pharma AB (publ) F:6XP	SE
A	Agnico Eagle Mines Ltd XMUN:AE9	CA
L	Lincoln National Corp XMUN:LCO	US
P	Panasonic Holdings Corp F:MAT1	JP
	Biogaia AB F:BGL	SE
U	US Bancorp F:UB5	US
A	Anglo American Platinum Ltd XMUN:RPHA	ZA
S	Sasol Ltd DUS:SAOA	ZA
	Ipsen SA F:I7G0	FR
H	Hess Corp XBER:AHC	US
O	Ollie's Bargain Outlet Holdings Inc F:OL6	US

Profitability Summary

Biomarin Pharmaceutical Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

80%

Strong 3Y Average Gross Margin

79%

Gross Margin is Increasing

77% > 80%

Low Operating Margin

10%

Sustainable 3Y Average Operating Margin

15%

Operating Margin is Increasing

3% > 10%

Low Net Margin

Sustainable 3Y Average Net Margin

11%

Net Margin is Increasing

3% > 8%

Exceptional Free Cash Flow Margin

23%

Strong 3Y Average Free Cash Flow Margin

14%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.